Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.1450 (-1.49%) ($38.1450 - $39.0800) on Wed. Oct. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.87% (three month average) | RSI | 35 | Latest Price | $38.1450(-1.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -2.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(49%) IWM(48%) IWC(45%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -0.935% in a week (0% probabilities). VIXM(-29%) VXX(-10%) UUP(-10%) GLD(-2%) TBT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.935% (StdDev 1.87%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $38.8 | 5 Day Moving Average | $38.03(0.3%) | 10 Day Moving Average | $37.7(1.18%) | 20 Day Moving Average | $38.8(-1.69%) | To recent high | -11.1% | To recent low | 4.4% | Market Cap | $5.213b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |